Regulatory And Cost Barriers Are Likely To Limit Biosimilar Development And Expected Savings In The Near Future
Data(s) |
01/06/2014
|
---|---|
Formato |
1048 - 1057 |
Identificador |
HEALTH AFFAIRS, 2014, 33 (6), pp. 1048 - 1057 0278-2715 |
Relação |
HEALTH AFFAIRS 10.1377/hlthaff.2013.0862 |
Tipo |
Journal Article |